HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings. Washaya T, Manasa J, Kouamou V. AIDS 2023;37:1629-1631.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Washaya T, Manasa J, Kouamou V. HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings. AIDS 2023;37:1629-1631.
PMID: 37450629